Zhi Zheng

Chengdu, 610095, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Deciphering the malignant synergy: metabolic reprogramming, epigenetic circuitry, and niche remodeling in osteosarcoma-macrophage crosstalk.

Deciphering the malignant synergy: metabolic reprogramming, epigenetic circuitry, and niche remodeling in osteosarcoma-macrophage crosstalk.

Journal: Frontiers in immunology

Published: May 19, 2026

Alisol B 23-acetate alleviates lipopolysaccharide-induced acute lung injury by targeting ANXA1 to modulate the ANXA1/FPR2-mediated MAPK/NF-κB signaling axis.

Alisol B 23-acetate alleviates lipopolysaccharide-induced acute lung injury by targeting ANXA1 to modulate the ANXA1/FPR2-mediated MAPK/NF-κB signaling axis.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: May 10, 2026

Targeting tumor‑associated macrophages in osteosarcoma: From molecular reprogramming to immuno-regenerative scaffolds.

Targeting tumor‑associated macrophages in osteosarcoma: From molecular reprogramming to immuno-regenerative scaffolds.

Journal: Pharmacological research

Published: March 31, 2026

Re-Arming the Immunological Radar: The Translational Landscape of Dendritic Cell-Centric Nanotherapeutics and Microenvironment Remodeling for Osteosarcoma.

Re-Arming the Immunological Radar: The Translational Landscape of Dendritic Cell-Centric Nanotherapeutics and Microenvironment Remodeling for Osteosarcoma.

Journal: International journal of nanomedicine

Published: March 27, 2026

Restoring immune homeostasis in the spinal microenvironment: targeting mechano-inflammation and immunometabolic reprogramming.

Restoring immune homeostasis in the spinal microenvironment: targeting mechano-inflammation and immunometabolic reprogramming.

Journal: Frontiers in immunology

Published: February 07, 2026

ABCC2 as a novel therapeutic target in lung adenocarcinoma: a machine learning-driven discovery linking ammonia metabolism to prognosis and drug resistance.

ABCC2 as a novel therapeutic target in lung adenocarcinoma: a machine learning-driven discovery linking ammonia metabolism to prognosis and drug resistance.

Journal: Journal of translational medicine

Published: December 23, 2025

Single-nucleus sequencing dissects the malignant change of early lung adenocarcinoma: SMAD3 suppresses antitumor T cell immunity via ICAM1.

Single-nucleus sequencing dissects the malignant change of early lung adenocarcinoma: SMAD3 suppresses antitumor T cell immunity via ICAM1.

Journal: NPJ precision oncology

Published: December 12, 2025

Metabolic reprogramming of CAR-T cells: a multi-pronged strategy to conquer the immunosuppressive tumor microenvironment.

Metabolic reprogramming of CAR-T cells: a multi-pronged strategy to conquer the immunosuppressive tumor microenvironment.

Journal: Cell communication and signaling : CCS

Published: November 17, 2025

Protocadherin gamma subfamily A, 3 inhibits the proliferation and metastasis of lung adenocarcinoma by inhibiting transforming growth factor β signaling pathway.

Protocadherin gamma subfamily A, 3 inhibits the proliferation and metastasis of lung adenocarcinoma by inhibiting transforming growth factor β signaling pathway.

Journal: Respiratory research

Published: November 14, 2025

Artificial intelligence in lung cancer: a bibliometric analysis of emerging trends and research hotspots.

Artificial intelligence in lung cancer: a bibliometric analysis of emerging trends and research hotspots.

Journal: Annals of medicine and surgery (2012)

Published: November 01, 2025

Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of diabetic kidney disease (DKD).

Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of diabetic kidney disease (DKD).

Journal: Cell death discovery

Published: June 28, 2025

Development and validation of a multimodal radiomics-serum biomarker model for diagnosing solid pulmonary nodules via machine learning.

Development and validation of a multimodal radiomics-serum biomarker model for diagnosing solid pulmonary nodules via machine learning.

Journal: Journal of thoracic disease

Published: June 16, 2025

Showing 1-12 of 26

Last Updated: 09/26/2026